Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age?
Daniele, B.; Simmonds, P.D.; Best, L.Y.; Ross, P.J.; Cunningham, D.
European Journal of Cancer 35(12): 1640-1649
1999
ISSN/ISBN: 0959-8049 PMID: 10674007 Document Number: 500558
Document emailed within 1 workday
Related Documents
Bucior, J.; Ziółko, E.; Tomczyk, A.; Sosada, K.; Knopik, J.; Kempiński, M. 2004: Effect of palliative chemotherapy with topoisomerase inhibitor on the quality of life and survival of patients with advanced colorectal carcinoma Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 17(101): 457-462Ogata, Y.; Sasatomi, T.; Mori, S.; Matono, K.; Ishibashi, N.; Akagi, Y.; Fukushima, T.; Murakami, H.; Ushijima, M.; Shirouzu, K. 2007: Significance of thymidine phosphorylase in metronomic chemotherapy using CPT-11 and doxifluridine for advanced colorectal carcinoma Anticancer Research 27(4c): 2605-2611
Zamurovic, M.; Jurisic, A.; Andjelic, S. 2010: Systemic chemotherapy--before or after radical surgery in treatment of patients with advanced ovarian carcinoma? European Journal of Gynaecological Oncology 31(5): 564-566
Serretta, V.; Vasile, P.; Falletta, V.; Piazza, F.; Pavone, C.; Pavone-Macaluso, M. 1998: Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 70(3 Suppl): 37-40
Misset, J.L. 1997: Chemotherapy of advanced colorectal cancers after failure of a treatment with fluoropyrimidine La Revue du Praticien 47(12 Spec No): S29-S35
Nishikawa, A.; Hashimoto, H.; Takeda, M.; Kontani, K.; Miyatake, T.; Mimura, M.; Nagamatsu, M.; Yokoi, T. 2016: Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy European Journal of Gynaecological Oncology 37(4): 451-454
Shimano, T.; Monden, T.; Morimoto, H.; Mori, T. 1990: The relation between serum carcinoembryonic antigen (CEA) and response to chemotherapy in patients with advanced colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(3 Part 2): 423-428
Takahashi, K.; Mori, T.; Yamaguchi, T.; Matsumoto, H.; Miyamoto, H.; Arai, K.; Iwasaki, Y.; Katayanagi, S. 2004: The present and future of home care chemotherapy for patients with advanced and recurrent colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(Suppl 2): 154-156
Yoshimatsu, K.; Yokomizo, H.; Fujimoto, T.; Umehara, A.; Otani, T.; Matsumoto, A.; Osawa, G.; Ogawa, K. 2007: Pilot study of simplified low-dose S-1 plus CPT-11 as first-line chemotherapy for patients with advanced colorectal cancer Anticancer Research 27(3b): 1657-1661
Pu, X.-x.; Deng, Y.-h.; Xu, F.; Xiao, J.; Guo, H.-q.; Huang, H.; Tian, Y.; He, Y.-j.; Lin, T.-y. 2009: Effect of KRAS mutation on efficacy of Cetuximab combined with chemotherapy in advanced colorectal cancer patients Zhonghua Wei Chang Wai Ke Za Zhi 12(6): 594-597
Chiappa, A.; Bertani, E.; Zbar, A.P.; Biffi, R.; Biella, F.; Bellomi, M.; Zampino, G.; Fazio, N.; Poldi, D.; Page, U.; Andreoni, B. 2007: Surgery for advanced colorectal cancer in elderly patients with special emphasis for radio-chemotherapy role Hepato-Gastroenterology 54(75): 740-745
Tauer, K.; Kemeny, N.; Cheng, E.; Hollander, P.; Geller, N. 1986: Phase Ii trial of N-methylformamide in patients with advanced colorectal carcinoma Cancer Treatment Reports 70(6): 813-814
Fiore, J.; Kemeny, N.; Raymond, V.; Young, C. 1986: Phase Ii trial of esorubicin in patients with advanced colorectal carcinoma Cancer Treatment Reports 70(10): 1241-1242
Viiachki, D.; Viiachki, I.; Penkov, N.; Khadzhidekov, V.; Mircheva, M. 1991: Intra-arterial chemotherapy in the treatment of liver metastases from colorectal carcinoma Khirurgiia 44(5): 1-7
Vitelli, C.E.; Fortunato, L.; Crenca, F.; Di Nardo, A.; Zarrelli, G.; Farina, M.; Bianca, S. 2005: Locally advanced and recurrent pelvic colorectal carcinoma: results of aggressive surgical treatment I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 4(3): S4
Cortesi, E.; Nelli, F. 2004: Chemotherapy in the treatment of advanced metastatic non-small cell carcinoma of the lung I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(2): S52-S55
Lei, Z.Y.; Guan, T.P.; Luo, J.L.; Tang, H.S.; Cui, S.Z. 2019: Rationality of performing hyperthermic intraperitoneal chemotherapy 5-8 weeks after primary tumor resection for patients with locally advanced colorectal cancer-based on COLOPEC Zhonghua Wei Chang Wai Ke Za Zhi 22(12): 1115-1117
Scott, W.W.; Gibbons, R.P.; Johnson, D.E.; Prout, G.R.; Schmidt, J.D.; Saroff, J.; Murphy, G.P. 1976: The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate Transactions of the American Association of Genito-Urinary Surgeons 68: 24-28
Longree, L.; Focan, C.; Dallemagne, B.; Delforge, M.; Jehaes, C.; Malherbe, R.; Mazy, V.; Markiewicz, S.; Weerts, J.; Lombard, R. 1992: Tolerance of adjuvant treatment combining postoperative intraportal chemotherapy and a systemic treatment based on 5-fluorouracil in colorectal carcinoma with a histologically poor prognosis Acta Gastro-Enterologica Belgica 55(4): 341-349
Zhang, T.; Su, D.; Li, J.; Wang, Y.; Han, C.; Jiao, S.; Bai, L. 2015: Clinical efficacy observation of cetuximab combined with chemotherapy in the treatment of metastatic colorectal carcinoma Zhonghua Wei Chang Wai Ke Za Zhi 18(6): 584-588